Snaterse, G., van Dessel, L., Taylor, A., Visser, J., Arlt, W., Lolkema, M., & Hofland, J. (2019). SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies. J Endocr Soc.
Citação norma ChicagoSnaterse, Gido, Lisanne van Dessel, Angela Taylor, Jenny Visser, Wiebke Arlt, Martijn Lolkema, and Johannes Hofland. "SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone As the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients On Second-Line Therapies." J Endocr Soc 2019.
MLA citiranjeSnaterse, Gido, et al. "SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone As the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients On Second-Line Therapies." J Endocr Soc 2019.